Cameroon vs Guatemala: New cases tested for RR-/MDR-TB
Cameroon
50.0%
in 2024
Guatemala
52.0%
in 2024
Cameroon rank
161st
Guatemala rank
160th
New cases tested for RR-/MDR-TB over time
- Cameroon
- Guatemala
How they compare
Guatemala currently reports 52.0% against 50.0% in Cameroon, a difference of 2.0%.
The two have swapped places 2 times across 13 shared years of data; in 2009 it was Guatemala ahead.
Cameroon ranks 161st and Guatemala ranks 160th of 192 countries.
Guatemala has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 8.0% | 8.0% | Guatemala |
| 2010s | 11.7% | 23.6% | 11.9% | Guatemala |
| 2020s | 37.0% | 78.8% | 41.8% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Cameroon or Guatemala?
- Guatemala, at 52.0% against 50.0% in Cameroon as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Cameroon and Guatemala?
- 2.0%, with Guatemala ahead.
- How many years of comparable data are there for Cameroon and Guatemala?
- 13 years are reported by both, from 2009 to 2024.
- How do Cameroon and Guatemala rank globally for new cases tested for rr-/mdr-tb?
- Cameroon ranks 161st and Guatemala ranks 160th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.